Lilly sues Indianapolis clinic for selling split doses of popular weight-loss drugs
Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular diabetes and weight-loss drugs.
Eli Lilly and Co.
-
Federal Circuit tweaks statute to overcome constitutionality concerns with administrative patent judges
On Halloween 2019, a constitutional argument against the process for challenging patents not only convinced a federal appellate court but also inspired the judges to offer their own fix to the statute.
Read More
Articles
LEAP spending nears $1B with projected budget shielded, investigation finds
The LEAP Research and Innovation District, led by the Indiana Economic Development Corp., is among the costliest economic development projects Indiana has attempted. But the agency’s structure obscures its spending and who benefits.
Medicaid coverage of weight-loss drugs could cost state up to $70 million a year
The Indiana Family and Social Service Administration’s Office of Medicaid Policy and Planning estimates that 5% to 20% of eligible members would be prescribed weight-loss medications.
Amid backlash, FDA changes course over shortage of Lilly weight-loss drugs
The U.S. Food and Drug Administration, after intense public pressure and a lawsuit, is reconsidering its declaration barely two weeks ago that a shortage of the appetite-suppressing drugs Mounjaro and Zepbound—both made by Indianapolis-based Eli Lilly and Co.—is over, a temporary about-face that will allow pharmacies to keep selling unbranded copies.
Lilly weight-loss drug copycat makers sue FDA for taking drugs off shortage list
A group representing companies that made copycat versions of Eli Lilly and Co.’s weight-loss drugs has sued the U.S. Food and Drug Administration over the agency’s decision to remove Lilly’s medications from its shortage list.
Lilly files suit against more spas, weight-loss centers selling knockoff version of its popular drugs
Just one month after settling with a South Carolina medical spa that was selling knockoff versions of its popular diabetes and weight-loss drugs, Eli Lilly and Co. is going after other sellers.
Federal judge grants collective status in suit brought by Lilly worker who claimed age bias
The ruling potentially opens the door to hundreds of Lilly employees over 40 years old who have been denied promotions for which they feel they were qualified.
Nevada company sues Lilly for breach of contract over Alzheimer’s drug
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.
Woman to plead guilty to leading conspiracy that defrauded Lilly of more than $600K
A Texas woman has agreed to plead guilty to leading a conspiracy to defraud Indianapolis-based drugmaker Eli Lilly and Co. out of more than $600,000 in false prescription savings cards.
Judge overturns $176.5M jury verdict against Lilly in patent infringement suit
A federal judge has overturned a $176.5 million jury verdict against Eli Lilly and Co., finding that the Indianapolis-based drugmaker did not infringe on the patents of a competitor in developing a treatment for migraine headaches.
Lilly files lawsuits over unauthorized versions of Mounjaro
Eli Lilly and Co. has filed lawsuits against 10 companies it accuses of selling unauthorized versions of its diabetes drug Mounjaro, Bloomberg News reported Tuesday.
Lilly, Novo Nordisk sued for alleged failure to warn about ‘severe’ side effects of popular diabetes drugs
Eli Lilly and Co. and the maker of diabetes drug Ozempic are being sued in federal court in Louisiana for allegedly failing to warn consumers and physicians about the risk of “severe gastrointestinal events” resulting from the use of two diabetes drugs.
Eli Lilly settles class-action insulin lawsuit for $13.5M
Eli Lilly and Co. has agreed to pay $13.5 million to settle a class-action lawsuit filed six years ago that alleged the Indianapolis-based drugmaker systematically overpriced its insulin.
Federal judge triples damages to $183M against Lilly in whistleblower suit
A federal judge in Illinois has tripled the damages in a jury verdict against Eli Lilly and Co., ruling that the drugmaker must pay $183.7 million in a lawsuit filed by a whistleblower who said the company made false claims about federal Medicaid rebates.
California to sue Lilly, other drug companies over insulin prices
California on Thursday announced it will sue the companies—including Indianapolis-based Eli Lilly and Co.—that make and promote most of the nation’s insulin.
Boone County residents file legal challenge over LEAP annexation
A group of Boone County residents filed legal action Tuesday against the city of Lebanon, accusing the municipality of violating state and local zoning law when it annexed 5,200 acres of land and created a new zoning district for a manufacturing and tech hub.
Pilot project designed to give second chance: Interdisciplinary Defense System brings together agencies to help individuals reentering society
With a game-changing grant of $4 million from the Lilly Endowment Inc., a long-discussed idea for creating a support network to help individuals reentering society after a period of incarceration is becoming a reality.
Suit accuses Lilly of illegally deducting funds from paychecks for vehicle use, extra time off
Eli Lilly and Co. illegally deducted millions of dollars from employee paychecks to pay for company vehicles and extra time off, a former sales representative claims in a federal lawsuit.
Holcomb defends abortion ban signing, rebuffs talent-attraction fears
Indiana Gov. Eric Holcomb on Wednesday defended his signing of a near-total abortion ban this month and brushed off fears of business and talent attraction consequences in the wake of statements from major homegrown employers.
Biden team, Eli Lilly condemn new Indiana abortion ban
The administration of President Joe Biden and one of Indiana’s largest employers have condemned the state’s new ban on abortions, with the White House calling it another extreme attempt by Republicans to trample women’s rights.